Page last updated: 2024-08-02 01:46:32

menaquinol 6

Description

menaquinol 6: a short chain analog of vitamin K2; physiological electron donor [MeSH]

menaquinol-6 : A menaquinol whose structure comprises a 2-methylbenzohydroquinone nucleus and a side chain of six isoprenoid units. [CHeBI]

Cross-References

ID SourceID
PubMed CID6441040
CHEBI ID84536
MeSH IDM0182489

Synonyms (11)

Synonym
menaquinol-6
menaquinol(6)
mkh2-6
menaquinol 6
2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl]-3-methylnaphthalene-1,4-diol
mqh2-6
39776-48-2
1,4-naphthalenediol, 2-(3,7,11,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaenyl)-3-methyl-
2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methylnaphthalene-1,4-diol
CHEBI:84536
Q27157840

Roles (1)

RoleDescription
electron donorA molecular entity that can transfer an electron to another molecular entity.

Drug Classes (1)

ClassDescription
menaquinolAny polyprenylhydroquinone having a polyprenyl moiety at position 2 and a methyl group at position 3..

Pathways (2)

menaquinol 6 is involved in 2 pathway(s), involving a total of 4 unique proteins and 29 unique compounds

PathwayProteinsCompounds
superpathway of menaquinol-6 biosynthesis I324
menaquinol-6 biosynthesis15

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (33.33)18.2507
2000's8 (53.33)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
menahydroquinone-4menaquinol00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
hydrogenelemental hydrogen;
elemental molecule;
gas molecular entity
antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
00low000000
2-hydroxypyrimidinehydroxypyrimidineelectron donor;
Lewis base
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
nitratesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
2003200321.0low000100
pentachlorophenolaromatic fungicide;
chlorophenol;
organochlorine pesticide;
pentachlorobenzenes
human xenobiotic metabolite1999200522.0low001100
thiosulfatesdivalent inorganic anion;
sulfur oxide;
sulfur oxoanion
human metabolite2012201212.0low000010
succinic acidalpha,omega-dicarboxylic acid;
C4-dicarboxylic acid
anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
1999199925.0low001000
2-(n-heptyl)-4-hydroxyquinoline n-oxidemonohydroxyquinoline1999200521.7low001200
diethyl pyrocarbonateacyclic carboxylic anhydride1998199826.0low001000
glutamineamino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2000200024.0low001000
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2005200519.0low000100
tyrosineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
2003200321.0low000100
histidineamino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2003200520.0low000200
argininearginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
2003200321.0low000100
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1990201921.0high006720
menadiolmethylnaphthalenes;
naphthalenediols;
naphthohydroquinone
2003200321.0low000100
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
2000200422.0low001100
glycidyl nitrate201920195.0low000010
diaminopimelic acid2,6-diaminopimelic acid;
amino acid zwitterion
Escherichia coli metabolite201920195.0low000010
fumaric acidbutenedioic acidfood acidity regulator;
fundamental metabolite;
geroprotector
1990199929.5low002000
stigmatellinaromatic ether;
chromones;
olefinic compound;
phenols
bacterial metabolite;
quinol oxidation site inhibitor
2003200321.0low000100
vitamin k semiquinone radical2003200321.0low000100
fumaratesbutenedioate;
C4-dicarboxylate
human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
1990199929.5low002000
ubiquinolpolyprenylhydroquinone;
ubiquinol
biomarker;
metabolite
1998200522.5low001100
cytochrome c-t2008200816.0low000100
ubiquinone1998200523.3low002100
chiniofon1999200521.7low001200
glycolipids201920195.0low000010
heme2001200819.8low000400
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020